Matthew Beard
3Patents
1h-index
8Co-inventors
33Inventor score
Filing activity: Oct 31, 2013 → Aug 27, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10030238B2 | Recombinant clostridium botulinum neurotoxins | Emerging Cross-Sectional Technologies | 7 | Active |
| US11193931B2 | Cellular vamp cleavage assay | Physics | 1 | Active |
| US12060553B2 | Evolution of BoNT peptidases | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.